Plunkett Research Online: Citius Pharmaceuticals Inc

CITIUS PHARMACEUTICALS INC (CTXR:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is primarily engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok.....



Citius Pharmaceuticals Inc
Ticker: CTXR
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 877 259-2551
Fax:
Address: 11 Commerce Drive
First Floor
Cranford, NJ 07016 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceutical Preparation Manufacturing
ContactsDescription
Myron HolubiakCEO/Director/President
Jaime BartushakCFO
See More
Citius Pharmaceuticals Inc is a specialty pharmaceutical company. The company is primarily engaged in the development and commercialization of anti-infective products, adjunctive cancer care, and unique prescription products. Citius is currently advancing two proprietary product candidates, Mino-Lok.....See More See More

Auditor: Wolf & Company, P.C.
Legal Advisor: BK Consulting & Associates, P.C.
$USD, In whole numbers,
except marked * or %
201720162015201320122011
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: